Case File №
#VI-2026-0676
Wuhan Newtop Biotech
Request Full Data Access to the VendorInvestigate database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| GHK-Cu | X Unrated | 1 | 4.1 | 4.1 | 4.1 | 25 May 2026 |
| Retatrutide | X Unrated | 1 | 7.8 | 7.8 | 7.8 | 25 May 2026 |
| 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Adipotide | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| AICAR | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Botulinum toxin | X N/A | 1 | 4.0 | 0.1 | 0.1 | 25 Apr 2025 |
| Bronchogen | X N/A | 1 | 4.0 | 0.3 | 0.3 | 9 Jun 2025 |
| Chonluten | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 0.6 | 0.6 | 28 Mar 2025 |
| Clomiphene (Clomid) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| DNP | X N/A | 1 | 4.0 | 1.5 | 1.5 | 27 Feb 2025 |
| EPO | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| GHRP-6 Acetate | X N/A | 1 | 4.0 | 1.4 | 1.4 | 9 Jun 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 4.0 | 0.4 | 0.4 | 16 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 13 Jun 2025 |
| Methylene Blue | X N/A | 1 | 4.0 | 0.7 | 0.7 | 14 Jan 2025 |
| MT-1 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| NAD+ | X N/A | 1 | 4.0 | 3.1 | 3.1 | 27 Feb 2025 |
| Orforglipron | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Ovagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Oxytocin Acetate | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Pancragen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Prostamax | X N/A | 1 | 4.0 | 3.1 | 3.1 | 14 Jan 2025 |
| Selank | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Sildenafil Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| SS-31 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 27 Feb 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Test Base (No Ester) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Testosterone Phenylpropionate Raw | X N/A | 1 | 4.0 | 0.2 | 0.2 | 8 Jul 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 4.0 | 2.0 | 2.0 | 24 Apr 2025 |
| TrenMix 200 | X N/A | 1 | 4.0 | 1.7 | 1.7 | 24 Apr 2025 |
| Turinabol | X N/A | 1 | 4.0 | 2.8 | 2.8 | 24 Apr 2025 |
Exhibit II
Evidence Log
35 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 4.3 C | 1g | 1.1g | +12.9% | 99.41% | 2yvnj3 | Lab A | Community |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 6.3 A | 50mg | 54.9mg | +9.8% | 95.91% | 9j808k | Lab A | Community |
| 24 May 2026 | CJC-1295 With DAC | 5.1 B | 5mg | 4.6mg | -8.9% | 99.87% | cr5eg4 | Lab C | Community |
| 24 May 2026 | Testosterone Phenylpropionate Raw | 4.0 C | 100g | 112.7g | +12.7% | 97.67% | vs4hmt | Lab C | Public |
| 24 May 2026 | TrenMix 200 | 6.1 A | 300mg/ml | 283.9mg/ml | -5.4% | 96.94% | 9k8fsg | Lab A | Community |
| 24 May 2026 | SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) | 4.0 C | 300mg/ml | 302.0mg/ml | +0.7% | 98.72% | kddhv8 | Lab E | Public |
| 23 May 2026 | Bronchogen | 5.3 B | 30mg | 28.9mg | -3.8% | 99.14% | ya7q7f | Lab F | Community |
| 21 May 2026 | MT-1 | 5.5 B | 2mg | 2.4mg | +20.8% | 97.55% | lroi3c | Lab F | Public |
| 20 May 2026 | Orforglipron | 4.5 C | 25mg | 30.1mg | +20.4% | 95.17% | y5o72z | Lab D | Public |
| 19 May 2026 | Adipotide | 4.5 C | 10mg | 12.1mg | +21.5% | 97.35% | mhe2pt | Lab F | Community |
| 19 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.3 C | 5mg | 5.2mg | +3.6% | 99.94% | g7gbi9 | Lab D | Community |
| 29 Jan 2026 | NAD+ | 4.0 C | 2mg | 1.7mg | -12.7% | 99.43% | 3rs95t | Lab A | Public |
| 29 Jan 2026 | Pancragen | 7.0 A | 15mg | 16.7mg | +11.4% | 96.39% | ksy1rs | Lab A | Public |
| 29 Jan 2026 | Thymosin Alpha-1 | 5.9 B | 30mg | 34.6mg | +15.2% | 98.49% | 711qgk | Lab D | Public |
| 26 Jan 2026 | AICAR | 4.0 C | 50mg | 61.4mg | +22.7% | 99.47% | 40ue1h | Lab A | Public |
| 26 Jan 2026 | Methylene Blue | 4.8 C | 20mg | 24.7mg | +23.3% | 95.96% | y6vmhd | Lab B | Public |
| 26 Jan 2026 | Sildenafil Raw | 4.8 C | 100g | 121.7g | +21.7% | 97.27% | 3acs6x | Lab G | Community |
| 19 Jan 2026 | Clomiphene (Clomid) Raw | 4.9 C | 10g | 10.5g | +4.7% | 99.41% | vea4c9 | Lab G | Community |
| 19 Jan 2026 | EPO | 5.8 B | 30mg | 30.8mg | +2.6% | 96.51% | ogiyas | Lab F | Public |
| 19 Jan 2026 | Oxytocin Acetate | 6.1 A | 10mg | 9.5mg | -4.7% | 98.09% | ofai1t | Lab A | Public |
| 9 Jan 2026 | DNP | 6.6 A | 25mg | 26.7mg | +6.7% | 95.68% | m3j3x5 | Lab B | Public |
| 7 Jan 2026 | Chonluten | 4.0 C | 20mg | 22.7mg | +13.4% | 97.16% | 04u5oj | Lab E | Community |
| 7 Jan 2026 | DHB (1-Test Cyp) Oral | 4.0 C | 10mg | 10.1mg | +1.0% | 97.32% | 0k3uic | Lab B | Public |
| 6 Jan 2026 | GHRP-6 Acetate | 4.0 C | 30mg | 37.5mg | +24.9% | 95.99% | wqxlpg | Lab B | Public |
| 29 Dec 2025 | Prostamax | 4.0 C | 2mg | 2.0mg | -0.3% | 98.62% | qpzhdn | Lab G | Public |
| 29 Dec 2025 | Selank | 4.0 C | 50mg | 44.3mg | -11.4% | 98.49% | iwbqni | Lab B | Public |
| 29 Dec 2025 | Turinabol | 4.9 C | 20mg | 22.5mg | +12.3% | 98.86% | ifxks2 | Lab E | Public |
| 12 Dec 2025 | Botulinum toxin | 5.7 B | 50mg | 56.5mg | +13.0% | 95.65% | q546iz | Lab G | Community |
| 12 Dec 2025 | SS-31 | 4.7 C | 15mg | 14.8mg | -1.2% | 96.76% | s1q0bq | Lab A | Public |
| 5 Dec 2025 | Masteron P (Drostanolone P) | 4.6 C | 250mg/ml | 234.3mg/ml | -6.3% | 97.66% | gafjnb | Lab G | Community |
| 17 Nov 2025 | Ovagen | 4.0 C | 2mg | 1.7mg | -14.8% | 96.34% | ic24t7 | Lab F | Public |
| 17 Oct 2025 | Tamoxifen (Nolvadex) | 4.0 C | 25mg | 26.2mg | +4.9% | 97.66% | qr5inx | Lab B | Community |
| 9 Oct 2025 | Test Base (No Ester) | 5.7 B | 250mg/ml | 229.6mg/ml | -8.1% | 96.37% | g9yue6 | Lab B | Public |
| 3 Oct 2025 | MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 | 4.0 C | 100g | 118.9g | +18.9% | 96.15% | midn5m | Lab B | Public |
| 3 Oct 2025 | PE 22-28 | 4.9 C | 20mg | 21.3mg | +6.7% | 97.27% | grmpu1 | Lab G | Community |